SynbiCITE is the UK's national centre for the commercialization of synthetic biology. As the Innovation and Knowledge Centre (IKC) for Synthetic Biology, it is based at Imperial College London. Their main objective is to accelerate and promote the commercial exploitation of synthetic biology research and engineering biology applications.

SynbiCITE brings together leading academic institutions, industrial partners, start-ups, and supporting organizations to bridge the gap between scientific research and commercialization. Established in 2013 with a £28 million commitment from various research councils and partners, SynbiCITE is committed to responsible innovation, considering ethical, societal, and environmental implications. Their vision is to create a globally renowned resource that fosters collaboration between academia, industry, and business to accelerate the commercialization of world-class science and emerging technologies in engineering biology.

They offer education and training opportunities, support the innovation process, and aim to grow the UK's synthetic biology industry through significant economic impact